| Primary |
| Premedication |
22.3% |
| Head And Neck Cancer |
11.9% |
| Colon Cancer |
11.1% |
| Non-small Cell Lung Cancer |
9.5% |
| Colorectal Cancer Metastatic |
7.9% |
| Colorectal Cancer |
6.3% |
| Rectal Cancer |
5.4% |
| Neoplasm Malignant |
4.8% |
| Squamous Cell Carcinoma |
2.8% |
| Colon Cancer Metastatic |
2.7% |
| Antiemetic Supportive Care |
2.5% |
| Oesophageal Adenocarcinoma |
2.2% |
| Tongue Neoplasm Malignant Stage Unspecified |
1.8% |
| Hypertension |
1.7% |
| Oesophageal Carcinoma |
1.5% |
| Tonsil Cancer |
1.4% |
| Drug Use For Unknown Indication |
1.1% |
| Pain |
1.1% |
| Prophylaxis |
1.1% |
| Laryngeal Cancer |
1.0% |
|
| Rash |
20.5% |
| Infusion Related Reaction |
14.1% |
| Vomiting |
7.6% |
| Hypersensitivity |
5.8% |
| Anaphylactic Reaction |
5.2% |
| Death |
5.0% |
| White Blood Cell Count Decreased |
3.7% |
| Malignant Neoplasm Progression |
3.6% |
| Dyspnoea |
3.2% |
| Pyrexia |
3.2% |
| Stomatitis |
3.2% |
| Hypomagnesaemia |
3.1% |
| Dermatitis Acneiform |
3.0% |
| Malaise |
3.0% |
| Weight Decreased |
2.9% |
| Adverse Event |
2.7% |
| Pruritus |
2.7% |
| Mucosal Inflammation |
2.6% |
| Urticaria |
2.6% |
| Thrombocytopenia |
2.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
11.9% |
| Colorectal Cancer Metastatic |
11.7% |
| Colorectal Cancer |
9.7% |
| Colon Cancer |
8.9% |
| Rectal Cancer |
8.7% |
| Premedication |
6.4% |
| Metastases To Liver |
5.7% |
| Head And Neck Cancer |
5.5% |
| Non-small Cell Lung Cancer |
4.3% |
| Rheumatoid Arthritis |
4.1% |
| Colon Cancer Metastatic |
3.7% |
| Product Used For Unknown Indication |
3.4% |
| Neoplasm Malignant |
2.7% |
| Pain |
2.5% |
| Squamous Cell Carcinoma |
2.3% |
| Gastric Cancer |
1.8% |
| Rectal Cancer Metastatic |
1.8% |
| Tonsil Cancer |
1.8% |
| Prophylaxis |
1.6% |
| Nausea |
1.5% |
|
| Vomiting |
20.3% |
| Pyrexia |
7.7% |
| White Blood Cell Count Decreased |
7.7% |
| Weight Decreased |
7.5% |
| Rash |
5.3% |
| Stomatitis |
4.9% |
| Pneumonia |
4.2% |
| Sepsis |
4.0% |
| Syncope |
3.7% |
| Tachycardia |
3.7% |
| Nausea |
3.5% |
| Thrombocytopenia |
3.5% |
| Urinary Tract Infection |
3.5% |
| Neutrophil Count Decreased |
3.3% |
| Diarrhoea |
3.1% |
| Neutropenia |
2.9% |
| Pulmonary Embolism |
2.9% |
| Renal Failure Acute |
2.9% |
| Dehydration |
2.7% |
| Acute Myocardial Infarction |
2.6% |
|
| Concomitant |
| Colon Cancer |
18.8% |
| Colorectal Cancer |
16.8% |
| Drug Use For Unknown Indication |
9.5% |
| Premedication |
7.7% |
| Colon Cancer Metastatic |
5.1% |
| Product Used For Unknown Indication |
4.9% |
| Colorectal Cancer Metastatic |
4.6% |
| Pain |
4.4% |
| Chemotherapy |
3.6% |
| Prophylaxis Of Nausea And Vomiting |
2.9% |
| Large Intestine Carcinoma |
2.8% |
| Lung Neoplasm Malignant |
2.8% |
| Rectal Cancer Metastatic |
2.8% |
| Non-small Cell Lung Cancer |
2.6% |
| Nausea |
2.3% |
| Adenocarcinoma Of Colon |
1.8% |
| Rectal Cancer |
1.8% |
| Anaemia |
1.6% |
| Anxiety |
1.6% |
| Breast Cancer |
1.6% |
|
| Vomiting |
14.2% |
| Death |
12.6% |
| Neuropathy Peripheral |
8.7% |
| Neutropenia |
6.3% |
| Vision Blurred |
6.3% |
| Weight Decreased |
5.5% |
| Disease Progression |
4.7% |
| Stomatitis |
4.7% |
| Thrombocytopenia |
4.7% |
| Pancytopenia |
3.9% |
| Thrombosis |
3.9% |
| Diarrhoea |
3.1% |
| Jaundice |
3.1% |
| Metastatic Squamous Cell Carcinoma |
3.1% |
| Tooth Loss |
3.1% |
| Back Pain |
2.4% |
| Dyspnoea |
2.4% |
| Hyperbilirubinaemia |
2.4% |
| Interstitial Lung Disease |
2.4% |
| Malignant Neoplasm Progression |
2.4% |
|
| Interacting |
| Colon Cancer |
36.4% |
| Premedication |
18.2% |
| Atrial Flutter |
9.1% |
| Blood Cholesterol Increased |
9.1% |
| Drug Use For Unknown Indication |
9.1% |
| Hyperlipidaemia |
9.1% |
| Hypothyroidism |
9.1% |
|
| Pleural Effusion |
50.0% |
| Systemic Inflammatory Response Syndrome |
50.0% |
|
